Literature DB >> 9707610

Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues.

J Irsch1, S Nitsch, M L Hansmann, K Rajewsky, H Tesch, V Diehl, A Jox, R Küppers, A Radbruch.   

Abstract

Hodgkin disease (HD) is characterized by a small number of malignant Hodgkin and Reed-Sternberg (H/RS) cells among a major population of nonmalignant cells. The analysis of H/RS cells has been hampered by their low frequency and fragility. Here, we describe the isolation of viable H/RS cells from HD affected tissues by high gradient magnetic cell sorting (MACS) according to expression of CD30. The cells were enriched to a purity of up to 50%. H/RS cells were distinguished from other CD30(+) cells by the expression of CD15, their size and granularity. No CD30/CD15 double-positive cells could be enriched from a lymph node affected by the lymphocyte predominant subtype of HD, activated lymph nodes or peripheral blood of healthy donors. For two cases of HD individual MACS-purified H/RS cells and H/RS cells micromanipulated from tissue sections of the same lymphoma specimens were analyzed for Ig gene rearrangements. In both cases, identical V gene rearrangements were amplified from both sources of H/RS cells, showing that H/RS cells were successfully enriched. Moreover, the finding that in both cases no additional Ig gene rearrangements other than the ones identified in the H/RS cells micromanipulated from tissue sections were amplified from the MACS-purified H/RS cells further supports the monoclonality of these cells throughout the affected lymph nodes. The isolation of viable H/RS cells ex vivo is prerequisite for a direct study of gene expression by those cells and of their interaction with cells in their vicinity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707610      PMCID: PMC21471          DOI: 10.1073/pnas.95.17.10117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Immunophenotype of Reed-Sternberg cells.

Authors:  J Hugh; S Poppema
Journal:  Int Rev Exp Pathol       Date:  1992

2.  Isolation and characterization of allergen-binding cells from normal and allergic donors.

Authors:  J Irsch; N Hunzelmann; H Tesch; H Merk; E Maggi; A Ruffilli; A Radbruch
Journal:  Immunotechnology       Date:  1995-08

Review 3.  The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease.

Authors:  R Küppers; K Rajewsky
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  On some Morbid Appearances of the Absorbent Glands and Spleen.

Authors: 
Journal:  Med Chir Trans       Date:  1832

5.  Switch recombination in normal IgA1+ B lymphocytes.

Authors:  J Irsch; S Irlenbusch; J Radl; P D Burrows; M D Cooper; A H Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single-cell study.

Authors:  J Delabie; A Tierens; T Gavriil; G Wu; D D Weisenburger; W C Chan
Journal:  Br J Haematol       Date:  1996-07       Impact factor: 6.998

7.  Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay.

Authors:  J Delabie; A Tierens; G Wu; D D Weisenburger; W C Chan
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

8.  Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

Authors:  J Wolf; U Kapp; H Bohlen; M Kornacker; C Schoch; B Stahl; S Mücke; C von Kalle; C Fonatsch; H E Schaefer; M L Hansmann; V Diehl
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease.

Authors:  H Dürkop; U Latza; M Hummel; F Eitelbach; B Seed; H Stein
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  7 in total

1.  Circulating clonotypic B cells in classic Hodgkin lymphoma.

Authors:  Richard J Jones; Christopher D Gocke; Yvette L Kasamon; Carole B Miller; Brandy Perkins; James P Barber; Milada S Vala; Jonathan M Gerber; Lan L Gellert; Mark Siedner; M Victor Lemas; Sarah Brennan; Richard F Ambinder; William Matsui
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

2.  Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.

Authors:  Mikhail Roshal; Brent L Wood; Jonathan R Fromm
Journal:  Adv Hematol       Date:  2010-11-28

3.  Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood.

Authors:  Joshua M Jackson; James B Taylor; Małgorzata A Witek; Sally A Hunsucker; Jennifer P Waugh; Yuri Fedoriw; Thomas C Shea; Steven A Soper; Paul M Armistead
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

4.  Rare occurrence of classical Hodgkin's disease as a T cell lymphoma.

Authors:  M Müschen; K Rajewsky; A Bräuninger; A S Baur; J J Oudejans; A Roers; M L Hansmann; R Küppers
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

5.  Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

Authors:  A Bräuninger; T Spieker; K Willenbrock; P Gaulard; H H Wacker; K Rajewsky; M L Hansmann; R Küppers
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

6.  Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield.

Authors:  T Seshadri; D Gook; S Lade; A Spencer; A Grigg; K Tiedemann; J McKendrick; P Mitchell; C Stern; J F Seymour
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

7.  Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens.

Authors:  Alexander Chan; Jose Victor Scarpa Carniello; Qi Gao; Allison Sigler; Jeeyeon Baik; Mikhail Roshal; Oscar Lin
Journal:  Arch Pathol Lab Med       Date:  2022-04-01       Impact factor: 5.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.